# A First-in-Human Study of QY101 Ointment in Adult Subjects

> **NCT05429177** · PHASE1 · COMPLETED · sponsor: **E-nitiate Biopharmaceuticals (Hangzhou) Co., Ltd.** · enrollment: 77 (actual)

## Conditions studied

- Healthy Volunteer

## Interventions

- **DRUG:** QY101 ointment or vehicle

## Key facts

- **NCT ID:** NCT05429177
- **Lead sponsor:** E-nitiate Biopharmaceuticals (Hangzhou) Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-06-08
- **Primary completion:** 2023-06-21
- **Final completion:** 2023-06-21
- **Target enrollment:** 77 (ACTUAL)
- **Last updated:** 2023-09-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05429177

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05429177, "A First-in-Human Study of QY101 Ointment in Adult Subjects". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT05429177. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*